PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; and.\', \'Second Department of Internal Medicine, Research Institute and Diabetes Center, \'Attikon\' University Hospital, National and Kapodistrian University of Athens, Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/FJC.0000000000001011
?:doi
?:hasPublicationType
?:journal
  • Journal of cardiovascular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34001719
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.917
?:rankingScore_hIndex
  • 89
is ?:relation_isRelatedTo_publication of
?:title
  • Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34001719>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34001719>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all